PPLPHARMA Piramal Pharma Ltd Earnings Reports Announcement 2025 - Financial Results Q3 Piramal Pharma Ltd reported a 14% growth in revenue and a 20% growth in EBITDA for the nine months ending December 2024, with significant improvements in their CDMO and CHG sectors..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Piramal Pharma Ltd